Gene Query: HDAC10

Dataset Description Geneva Score
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 25.8
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 19.72
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 16.42
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 16.26
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 16.15
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 15.82
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 14.95
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 14.44
Silencing SPIB in attached and floating state of H1703 lung cancer cells 13.25
Pharmacologic inhibition of STAT5 in AML 13.12
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 11.7
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.48
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.14
Effect of mitochondria deficiency on senescence-associated gene expression 10.62
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 10.47
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.33
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.28
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 9.99
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 9.84
H1609088 Human RNA-Sequencing 9.69
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.67
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.67
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.61
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 9.5
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 9.48
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 9.39
Paxillin regulates genomic networks in prostate cancer [PC3] 8.72
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.61
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.4
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 8.28
Intrahepatic MAIT cell gene expression revealed by RNA-seq 8.05
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.91
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.91
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.84
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.79
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.74
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.35
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 7.35
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 7.26
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 7.23
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 7.23
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.18
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 7.09
Primary Human B-cell Temporal Response to CD40L Stimulation 6.94
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.93
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.84
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.78
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.68
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 6.56
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.48
Transcriptional changes in lymphoma cells induced by LSD1 depletion 6.37
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 6.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.34
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.27
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.19
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.18
Transcription control by the ENL YEATS domain in acute leukemia 5.93
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 5.93
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 5.92
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.92
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 5.77
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.76
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.71
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.71
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 5.68
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.65
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.53
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 5.52
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 5.52
FOXP2's impact on the primate transcriptome 5.45
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.42
Transciptomic profiling of human fetal lung samples 5.41
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.34
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.34
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.34
ENCODE Cold Spring Harbor Labs Long RNA-seq 5.3
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 5.22
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.17
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.09
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.05
RNAseq Analysis in glioblastoma cells treated with Mepazine 5.05
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.05
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.91
Noncoding regions are the main source of targetable tumor-specific antigens 4.88
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.88
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.8
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.76
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.68
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.68
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 4.62
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 4.62
The effect of PPARG inhibition on human angiomyolipoma cells 4.6
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.57
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.53
Microglia innatly develop within cerebral organoids 4.43
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.42
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.42
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.42
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 4.41
Targeted enhancer activation by a subunit of the integrator complex 4.36
Impact of dieldrin on transcription in Jurkat T cells 4.31
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 4.18
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.17
Genome-wide functional assessment of enhancer activities in the human genome 4.17
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 4.08
Gene expression in GBM with Cav3.2 inhibition 4.08
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 4.07
Gene expression profiling of leukemia cells following asparagine depletion 4.06
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.0
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.0
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.92
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.9
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 3.89
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 3.88
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 3.88
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.86
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.79
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.77
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.71
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.68
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.67
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.67
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.65
RIG-I and MDA5 fRIP during KSHV lytic reactivation 3.61
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.59
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 3.56
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.53
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.53
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.51
U1 snRNP telescripting regulates size-function stratified human genome 3.5
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 3.44
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.43
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 3.42
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.42
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.41
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.41
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.33
DART-seq: an antibody-free method for global m6A detection 3.3
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.29
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.28
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.25
3.24
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.23
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 3.22
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.22
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 3.17
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.17
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.15
Identification of Sin3B regulated genes during quiescence 3.13
BACH2 in human plasma cell fate decision 3.13
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.12
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.11
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.11
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 3.11
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.08
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 3.07
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.07
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.07
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 3.06
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.04
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.03
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.03
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 3.03
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.03
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.02
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 3.0
Chromatin-informed inference of transcriptional programs in gynecologic cancers 3.0
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.99
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.97
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.97
High-Throughput Kinetic Analysis of Fractional Killing 2.97
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.96
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.96
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.95
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.93
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.92
RNA-Seq and expression data from human adipose tissue 2.92
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 2.91
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.91
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.89
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.89
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.88
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 2.87
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.86
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.86
Transcriptome Profiling of Human Primary Monocytes 2.86
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.85
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.85
RNA-seq analysis upon ARID1B overexpression 2.84
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.83
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 2.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 2.83
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.82
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.81
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.81
The evolution of N6-methyladenosine in primates 2.8
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 2.79
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.77
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 2.76
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.74
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.71
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.7
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.7
Transcriptome wide analysis of classically and alternatively activated macrophages 2.69
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 2.69
Identification of long noncoding RNAs in T-ALL cell lines 2.67
Glioblastoma stem cells infected by ZIKA virus 2.65
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.63
Global epigenomic reconfiguration during mammalian brain development 2.61
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.6
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.59
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.58
NR2F2 study 2.56
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.56
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.56
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.55
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.54
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.52
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.52
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.51
quanTIseq: quantifying immune contexture of human tumors 2.48
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.47
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.45
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 2.45
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 2.44
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 2.44
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 2.43
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.41
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.41
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.41
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.38
Bone marrow derived human B cells [normal proB] 2.38
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.38
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.38
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.38
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.37
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.35
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.35
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.34
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.32
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 2.29
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 2.29
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.28
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.27
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.26
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.25
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.25
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.22
Transcriptome analysis of SKI knock-out in HL60 cells 2.22
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.22
Transcriptional responses of melanoma cells to BRAF inhibition 2.22
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.2
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.2
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.16
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.15
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.11
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.11
X-Ray induced DNA-Hydroxymethylation changes 2.11
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 2.1
IL-33 activates tumor stroma to promote intestinal polyposis 2.07
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.07
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.05
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.05
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.05
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.01
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.01
Functional significance of the HIV-1 Tat signature amino acid residues 2.01
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.01
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
Intron retention induced by microsatellite expansions as a disease biomarker. 2.0
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.98
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.95
CUREfast: Accelerating research with families 1.94
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.93
Gene expression analysis upon mtDNA depletion 1.93
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.93
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.91
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.9
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.88
Effect of PBK knockdown on C4-2 cell transcriptome 1.87
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.85
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.85
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.84
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 1.83
Single-cell analysis of adult human ovary using 10X genomics 1.83
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.83
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.82
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.78
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.78
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.78
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.77
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.75
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.75
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.75
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.74
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.73
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.71
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.7
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.68
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.66
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.66
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.64
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.64
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.64
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.6
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.59
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.58
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.55
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.55
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.55
Dysregulated immune system networks in war veterans with PTSD 1.55
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.52
The role of m6A/m-RNA methylation in stress response regulation 1.51
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.51
Regulation of poly(A) tail and translation during the somatic cell cycle 1.51
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.5
RNA polymerase in pre-B-ALL cell lines 1.47
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.47
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.44
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.44
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.44
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 1.42
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 1.42
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.4
Clinker: visualizing fusion genes detected in RNA-seq data 1.4
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.4
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.4
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.39
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.37
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.37
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.36
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.36
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.36
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 1.34
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 1.34
CD86 regulates a pro-survival signal in myeloma cells 1.33
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.31
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.31
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.3
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.3
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.25
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.24
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.21
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.21
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.21
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.21
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.2
Gene expression analysis of human adenomas. 1.18
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.18
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.18
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.15
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.15
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.14
RNA sequencing of human pancreatic cancer cell lines 1.12
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.1
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 1.1
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 1.1
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.08
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.08
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.08
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.06
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.06
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.05
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.04
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.04
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.03
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.0
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.96
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.96
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.95
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.95
Energy Metabolism during Anchorage-Independence 0.94
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.92
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.91
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.91
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.9
Investigate A2M treatment on human prostate cancer and mouse liver 0.89
Investigate A2M treatment on human prostate cancer xenograft in mice 0.89
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.89
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.88
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.88
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.86
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.85
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.85
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.83
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.83
Analyses of T-ALL (COG study) 0.81
RNA sequencing of T-ALL (COG study) 0.81
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.79
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.77
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.74
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.73
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 0.73
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.71
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.71
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.71
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.7
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.7
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.69
Downregulation of LATS kinases alters p53 to promote cell migration 0.68
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.68
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.66
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.64
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.64
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.63
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.63
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.62
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.62
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.61
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.6
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.57
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.57
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.57
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.56
DRB/GRO-Seq -/+ UV 0.56
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.55
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.55
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.54
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.51
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.51
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.49
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.49
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.49
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.46
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.44
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.44
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.44
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.43
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.43
Preclinical model of obesity and ER-positive breast cancer 0.43
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.43
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.41
The transcriptome effect of overexpressing EZH2 in MCF7 0.41
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.41
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.41
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.4
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.39
iPSC derived motor neuron cultures from C9ORF72 carriers 0.39
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.38
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.38
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.37
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.37
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 0.34
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.33
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.33
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.3
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.28
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.27
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.27
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.25
MHC Transcriptomic landscape at haplotype-specific resolution 0.25
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.24
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.22
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.22
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.22
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.21
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.21
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.2
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.2
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.19
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.19
miRNAs affected by antagomiR-17 treatment 0.18
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.18
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.18
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.17
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.17
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.17
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.15
Hepatic transcriptome of pediatric hepatoblastoma. 0.14
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.13
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.13
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.13
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.12
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.12
naive T cell heterogeneity after neonatal thymectomy 0.12
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.12
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.12
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.11
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.11
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.1
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.1
Function and hormonal regulation of GATA3 in human first trimester placentation 0.1
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.08
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.07
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.06
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.06
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.05
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.04
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.04
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 0.02
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 0.02
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.01
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation